产品标题 产品货号 产品规格 厂家
Foxh1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5060811 kitORIGENE TECHNOLOGIES
FOXI3 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN2275391 kitORIGENE TECHNOLOGIES
FOXI3 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN227539BN1 kitORIGENE TECHNOLOGIES
FOXI3 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN227539LP1 kitORIGENE TECHNOLOGIES
FOXI3 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN227539RB1 kitORIGENE TECHNOLOGIES
FOXI1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4064301 kitORIGENE TECHNOLOGIES
FOXI2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4169611 kitORIGENE TECHNOLOGIES
FOXI3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4275391 kitORIGENE TECHNOLOGIES
Foxi1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5060821 kitORIGENE TECHNOLOGIES
Foxi2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5060831 kitORIGENE TECHNOLOGIES
Foxi3 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5060841 kitORIGENE TECHNOLOGIES
FOXI1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30643010 ugORIGENE TECHNOLOGIES
Human Urinary bladder; Cystitis of urinary bladder, granulomatous from ORIGENE TECHNOLOGIESCS5052755x5umORIGENE TECHNOLOGIES
Human Urinary bladder; No residual malignancy from ORIGENE TECHNOLOGIESCS7080105x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Granuloma of bladder from ORIGENE TECHNOLOGIESCS7049825x5umORIGENE TECHNOLOGIES
Human Urinary bladder; No residual malignancy from ORIGENE TECHNOLOGIESCS7080115x5umORIGENE TECHNOLOGIES
Human Urinary bladder; No residual malignancy from ORIGENE TECHNOLOGIESCS5260565x5umORIGENE TECHNOLOGIES
Human Urinary bladder; No residual malignancy from ORIGENE TECHNOLOGIESCS5260575x5umORIGENE TECHNOLOGIES
Human Urinary bladder; No residual malignancy from ORIGENE TECHNOLOGIESCS5260585x5umORIGENE TECHNOLOGIES
Human Urinary bladder, normal from ORIGENE TECHNOLOGIESCS7049855x5umORIGENE TECHNOLOGIES
Human Urinary bladder, normal from ORIGENE TECHNOLOGIESCS5048455x5umORIGENE TECHNOLOGIES
Human Urinary bladder, normal from ORIGENE TECHNOLOGIESCS5048465x5umORIGENE TECHNOLOGIES
Human Urinary bladder, normal from ORIGENE TECHNOLOGIESCS5184385x5umORIGENE TECHNOLOGIES
Human Urinary bladder, normal from ORIGENE TECHNOLOGIESCS5240625x5umORIGENE TECHNOLOGIES
Human Urinary bladder, normal from ORIGENE TECHNOLOGIESCS5320715x5umORIGENE TECHNOLOGIES
Human Urinary bladder, normal from ORIGENE TECHNOLOGIESCS5354745x5umORIGENE TECHNOLOGIES
Human Urinary bladder, normal from ORIGENE TECHNOLOGIESCS5517495x5umORIGENE TECHNOLOGIES
Human Urinary bladder, normal from ORIGENE TECHNOLOGIESCS5573955x5umORIGENE TECHNOLOGIES
Human Urinary bladder, normal from ORIGENE TECHNOLOGIESCS6107775x5umORIGENE TECHNOLOGIES
Human Urinary bladder, normal from ORIGENE TECHNOLOGIESCS6180035x5umORIGENE TECHNOLOGIES
Human Urinary bladder, normal from ORIGENE TECHNOLOGIESCS6354805x5umORIGENE TECHNOLOGIES
Human Urinary bladder, normal from ORIGENE TECHNOLOGIESCS6363615x5umORIGENE TECHNOLOGIES
Human Urinary bladder, normal from ORIGENE TECHNOLOGIESCS6482615x5umORIGENE TECHNOLOGIES
Human Urinary bladder, normal from ORIGENE TECHNOLOGIESCS6512235x5umORIGENE TECHNOLOGIES
Human Urinary bladder, normal from ORIGENE TECHNOLOGIESCS6512265x5umORIGENE TECHNOLOGIES
Human Urinary bladder, normal from ORIGENE TECHNOLOGIESCS8147785x5umORIGENE TECHNOLOGIES
Human Urinary bladder, normal (protein lysate) from ORIGENE TECHNOLOGIESCP565517150 ugORIGENE TECHNOLOGIES
Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 (MLLT3) from ORIGENE TECHNOLOGIESLY401439100 ugORIGENE TECHNOLOGIES
Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 (MLLT6) from ORIGENE TECHNOLOGIESLY416978100 ugORIGENE TECHNOLOGIES
Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 (MLLT10), transcript variant 1 from ORIGENE TECHNOLOGIESLY417852100 ugORIGENE TECHNOLOGIES
Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 (MLLT4), transcript variant 2 from ORIGENE TECHNOLOGIESLY421870100 ugORIGENE TECHNOLOGIES
Myeloid zinc finger 1 (MZF1), transcript variant 1 from ORIGENE TECHNOLOGIESLY418714100 ugORIGENE TECHNOLOGIES
Myeloid zinc finger 1 (MZF1), transcript variant 2 from ORIGENE TECHNOLOGIESLY405081100 ugORIGENE TECHNOLOGIES
Myeloma overexpressed (in a subset of t(11;14) positive multiple myelomas) (MYEOV) from ORIGENE TECHNOLOGIESLY408509100 ugORIGENE TECHNOLOGIES
Myeloperoxidase (MPO), nuclear gene encoding mitochondrial protein from ORIGENE TECHNOLOGIESLY424842100 ugORIGENE TECHNOLOGIES
Myeloproliferative leukemia virus oncogene (MPL) from ORIGENE TECHNOLOGIESLY417351100 ugORIGENE TECHNOLOGIES
MYEOV2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4120801 kitORIGENE TECHNOLOGIES
MYEOV - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4041251 kitORIGENE TECHNOLOGIES
Myeov2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5105851 kitORIGENE TECHNOLOGIES
MYF6 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4047051 kitORIGENE TECHNOLOGIES
 |< < 2044 2045 2046 2047 2048 2049 2050 2051 2052 > >| 第 2050/6274 页